“johns-hopkins-university” Archives

in
Entry Author Date Location
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
Frequency Nabs $32M, Will Push Hearing-Loss Drugs To Human Studies 04/11/17 Boston
Proteon’s Blood Vessel Drug Flunks Main Phase 3 Test, Shares Plummet 12/13/16 Boston
How to Make Healthcare Better? Make It Easy 06/08/16 Boston
Redox Picked to Join Cisco’s Entrepreneurs in Residence Program 06/07/16 Wisconsin
GenSpera, Pursuing Partners, Tests Toxin-Based Drug in Brain Cancer 02/03/16 Texas
Salk Recruits Nobel Laureate Liz Blackburn as First Woman President 11/19/15 San Diego
Bristol-Myers to Add Cardioxyl’s Heart Failure Drug With $300M Deal 11/02/15 Raleigh Durham
Bought By Utah Rival Tute, Former Genomics High Flyer Knome Bows Out 11/02/15 Boston
Redox Nabs East Coast Money to Develop Plug-and-play Healthcare API 10/20/15 Wisconsin
Versant Walks Biotech “High Line” With a New Manhattan Incubator 08/24/15 New York
With PCSK9’s Origins In Mind, Sanofi Has UT Join Funding Program 07/09/15 Texas
ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer 04/21/15 Boston
Curoverse Begins Trial Run for Open Source Genomics Tool 04/14/15 Boston
Six Takeaways From “New York’s Life Science Disruptors” 03/16/15 New York
Madison Vaccines Expands Series A To Advance Prostate Cancer Drugs 03/10/15 Wisconsin
East Coast Biotech Roundup: Regeneron, Sarepta, Jounce, & More 07/11/14 Boston
Texas Roundup: Funds for FireHost, Silvercar; UTSA Joins Microsoft 04/18/14 Texas
Proteon, Looking Past Ill-Fated Novartis Deal, Goes it Alone 03/18/14 Boston
East Coast Biotech Roundup: VentriNova, RainDance, Biogen, & More 03/07/14 Boston
Sports Apps, ‘Telemedicine’ for Business Among DreamIt Startups 01/10/14 Texas
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
Vertex Pharmaceuticals Booms on Cystic Fibrosis Combo Drug Study 04/18/13 Boston
Blueprint Health Demo Day Reveals Ideas for Hospital Efficiency 04/08/13 New York
Kala Pharma, From MIT & Johns Hopkins, Grabs $11.5M for Eye Drugs 02/28/13 Boston
The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More 01/13/12 Boston
Knome Names New CEO, Cuts Deal With Johns Hopkins to Analyze 1,000 Genomes 01/09/12 Boston
Veracyte Finds a Way to Make a Buck Cutting Waste in Thyroid Cancer Treatment 11/18/11 San Francisco
Xconomist of the Week: Tony Coles’ Journey from Mass General Doctor to SF Biotech CEO 08/18/11 National
Computing in the Age of the $1,000 Genome: Speakers from Isilon, Arch Join Stellar Lineup 12/27/10 Seattle
Page 1 of 2 next page »